live attend influenza vaccine laid prevent morbid mortal assoc viral infect mani year metres best therapeutic option protect human howe develop trait reli empire method adapt virus replica low temperature approach require extent invest time resource identify potent vaccine candid safe implement admit meghan attend poorly understood case importantly efficacy inactive bail mount office innate adapt humor cellular immune response therefore design base known property protein appear highly appropri treatment rna synthesis machinery research focus identify key amino acid substitute lead use safe immunogen protect review discus manipul rnadepend polymerase rdr complex genre form virus use one current effect prophylact option control 